oral pharmacologic treatment of type 2 diabetes mellitus
Diabetes mellitus is a common secondary diagnosis in hospitalized patients. in 1988, diabetes was one of the diagnoses recorded for 2.8 million patients discharged.
Traditionally, it has been recommended that therapy be adjusted to maintain hba1c values near or below 7% in nonpregnant adults. for patients with type 1 dm or type 2. Diabetes mellitus is a common secondary diagnosis in hospitalized patients. in 1988, diabetes was one of the diagnoses recorded for 2.8 million patients discharged. Key clinical points glycemic control in type 2 diabetes mellitus. intensive glycemic control reduces the risk of microvascular complications of type 2 diabetes, but.
Key clinical points glycemic control in type 2 diabetes mellitus. intensive glycemic control reduces the risk of microvascular complications of type 2 diabetes, but.
Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the american college of physicians free. The prevalence of type 2 diabetes continues to increase steadily as more people live longer and grow heavier. from 1995 to 2004, the overall prevalence of type 2. Type 2 diabetes spans a continuum from impaired glucose tolerance and impaired fasting glucose to frank diabetes that results from progressive.
